Skip to main content

Surgery for Bronchoalveolar Lung Cancer

  • Chapter
Difficult Decisions in Thoracic Surgery

Abstract

Bronchoalveolar carcinoma (BAC) is a distinct subtype of non-small cell lung adenocarcinoma classified by the World Health Organization (WHO) as a peripheral well-differentiated neoplasm demonstrating lepidic spread along preexisting alveolar structures. An important histological feature is the preservation of the underlying lung architecture and the absence of invasion into stroma, pleura, or lymphatics of all pure BACs. Lung adenocarcinomas with a BAC component are now more appropriately classified as adenocarcinomas, mixed subtype. Despite the WHO designation as a subtype of adenocarcinoma, BAC has pathological, radiologic, and clinical features that are distinct from those of adenocarcinomas.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Travis WD, Garg K, Franklin WA, et al. Evolving concepts I the pathology and computed tomography imaging of lung adenocarcinoma and bronchioalveolar carcinoma. J Clin Oncol 2005;23:3279–3287.

    Article  PubMed  Google Scholar 

  2. Jackman DM, Chirieac LR, Janne PA. Bronchioalveolar carcinoma: a review of the epidemiology, pathology and treatment. Semin Respir Crit Care Med 2005;26:342–352.

    Article  PubMed  Google Scholar 

  3. Laskin JJ. Bronchoalveolar carcinoma: current treatment and future trends. Clin Lung Cancer 2004;S75–S79.

    Google Scholar 

  4. Read WL, Page NC, Tierney RM, et al. The epidemiology of bronchioalveolar carcinoma over the past two decades: analysis of the SEER database. Lung Cancer 2004;45:137–142.

    Article  PubMed  Google Scholar 

  5. Sabloff BS, Truong MT, Wistuba II, et al. Bronchioalveolar cell carcinoma: radiologic appearance and dilemmas in the assessment of response. Clin Lung Cancer 2004;6:108–112.

    PubMed  Google Scholar 

  6. Lee KS, Kim Y, Han J, et al. Bronchioloalveolar carcinoma: clinical, histopathologic, and radiologic findings. Radiographics 1997;17:1345–1357.

    PubMed  CAS  Google Scholar 

  7. Patel JD. Role of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of bronchoalveolar carcinoma. Clin Lung Cancer 2004;6:S43–S47.

    PubMed  CAS  Google Scholar 

  8. Akira M, Atagi S, Kawahara M, et al. High-resolution CT findings of diffuse bronchoalveolar carcinoma in 38 patients. AJR Am J Roentgenol 1999;173:1623–1629.

    PubMed  CAS  Google Scholar 

  9. Yap CS, Schiepers C, Fishbeln MC, et al. FDG-PET imaging in lung cancer: how sensitive is it for bronchoalveolar carcinoma? Eur J Nucl Med 2002;29:1166–1173.

    Article  CAS  Google Scholar 

  10. Heyneman LE, Patz EF. PET imaging in patients with bronchioalveolar cell carcinoma. Lung Cancer 2002;38:261–266.

    Article  PubMed  Google Scholar 

  11. Nakajima R, Yokose T, Kakinuma R, et al. Localized pure ground-glass opacity on high-resolution CT: histologic characteristics. J Comput Assisted Tomogr 2002;26:323–329.

    Article  Google Scholar 

  12. Jang HJ, Lee KS, Kwon OJ, et al. Bronchioalveolar carcinoma: focal area of ground glass attenuation at thin-section CT as an early sign. Radiology 1996;199:485–488.

    PubMed  CAS  Google Scholar 

  13. Kakinuma R, Oshmatsu H, Kaneko M, et al. Progression of focal pure ground-glass opacity detected by low dose helical computed tomography screening for lung cancer. J Comput Assist Tomogr 2004;28:17–23.

    Article  PubMed  Google Scholar 

  14. Altorki NK. Bronchioalveolar carcinoma and groundglass opacities. Ann Thorac Surg 2005;80:1560–1561.

    Article  PubMed  Google Scholar 

  15. Grover FL, Piantadosi S, and The Lung Cancer Study Group. Recurrence and survival following resection of bronchioalveolar carcinoma of the lung. The Lung Cancer Study Group experience. Ann Surg 1989;206:779–790.

    Article  Google Scholar 

  16. Daly RC, Trastek VF, Pairolero PC, et al. Bronchoalveolar carcinoma: factors affecting survival. Ann Thorac Surg 1991;51:368–377.

    Article  PubMed  CAS  Google Scholar 

  17. Dumont P, Gasser B, Roughe C, et al. Bronchoalveolar carcinoma. Histopathologic study of evolution in a series of 105 surgically treated patients. Chest 1998;113:391–395.

    PubMed  CAS  Google Scholar 

  18. Regnards JF, Santelmo N, Romdhani N, et al. Bronchioalveolar lung carcinoma. Results of lsurgical treatment and prognostic factors. Chest 1998;114:45–50.

    Google Scholar 

  19. Ebright MI, Zakowski MF, Martin J, et al. Clinical pattern and pathologic stage but not histologic features predict outcome for bronchoalveolar carcinoma. Ann Thorac Surg 2002;74:1640–1647.

    Article  PubMed  Google Scholar 

  20. Breathnach OS, Kwiatkowski DJ, Finkelstein DM, et al. Bronchioloalveolar carcinoma of the lung: recurrences and survival in patients with stage I disease. J Thorac Cardiovasc Surg 2001;121:42–47.

    Article  PubMed  CAS  Google Scholar 

  21. Rena O, Papilia E, Ruffini E, et al. Stage I pure bronchioloalveolar carcinoma: recurrences, survival and comparison with adenocarcinoma of the lung. Eur J Cardiothorac Surg 2003;23:409–414.

    Article  PubMed  Google Scholar 

  22. Sakurai H, Dobashi Y, Mizutani E, et al. Bronchioloalveolar carcinoma of the lung 3 centimeters or less in diameter: a prognostic assessment. Ann Thorac Surg 2004;78:1728–1733.

    Article  PubMed  Google Scholar 

  23. Ginsberg R, Rubinstein L. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995;60:615–622.

    Article  PubMed  CAS  Google Scholar 

  24. Miller DL, Rowland CM, Deschamps C, et al. Surgical treatment of non-small cell lung cancer 1 cm or less in diameter. Ann Thorac Surg 2002;73:1545–1550.

    Article  PubMed  Google Scholar 

  25. Yamato Y, Tsuchida M, Watanabe T, et al. Early results of a prospective study of limited resection for bronchoalveolar adenocarcinoma of the lung. Ann Thorac Surg 2001;71:971–974.

    Article  PubMed  CAS  Google Scholar 

  26. Watanabe S, Watanabe T, Arai K, et al. Results of wedge resection for focal bronchioloalveolar carcinoma showing pure ground-glass attenuation on computed tomography. Ann Thorac Surg 2002;73:1071–1075.

    Article  PubMed  Google Scholar 

  27. Nakata M, Sawada S, Saeki H, et al. Prospective study of thorascopic limited resection for ground-glass opacity selected by computed tomography. Ann Thorac Surg 2003;75:1601–1606.

    Article  PubMed  Google Scholar 

  28. Yamada S, Kohno T. Video-assisted thoracic surgery for pure ground-glass opacities 2 cm or less in diameter. Ann Thorac Surg 2004;77:1911–1915.

    Article  PubMed  Google Scholar 

  29. Okubo K, Mark EJ, Flieder D, et al. Bronchoalveolar carcinoma: clinical, radiologic, and pathologic factors and survival. J Thorac Cardiovasc Surg 1999;118:702–709.

    Article  PubMed  CAS  Google Scholar 

  30. Liu YY, Chen YM, Huang MH, et al. Prognosis and recurrent patterns in bronchioloalveolar carcinoma. Chest 2000;118:940–947.

    Article  PubMed  CAS  Google Scholar 

  31. Furak J, Trojan I, Szoke T, et al. Bronchioloalveolar lung cancer: occurrence, surgical treatment and survival. Eur J Cardiothorac Surg 2003;23:818–823.

    Article  PubMed  Google Scholar 

  32. Matsuguma H, Nakahara R, Anraku M, et al. Objective definition and measurement method of ground-glass opacity for planning limited resection in patients with clinical stage IA adenocarcinoma of the lung. Eur J Cardiothorac Surg 2004;25:1102–1106.

    Article  PubMed  Google Scholar 

  33. Kodama K, Higashiyama M, Yokouchi H, et al. Prognostic valve of ground-glass opacity found in small lung adenocarcinoma on high-resolution CT scanning. Lung Cancer 2001;33:17–25.

    Article  PubMed  CAS  Google Scholar 

  34. Namori H, Ohtsuka T, Naruke T, et al. Histogram analysis of computed tomography numbers of clinical T1 N0 M0 lung adenocarcinoma with special reference to lymph node metastasis and tumor invasiveness. J Thorac Cardiovasc Surg 2003;126:1584–1589.

    Article  Google Scholar 

  35. Suzuki K, Asamua H, Kusumoto M, et al. Early peripheral lung cancer: prognostic significance of ground glass opacity on thin-section computed tomographic scan. Ann Thorac Surg 2002;74:1635–1639.

    Article  PubMed  Google Scholar 

  36. Higashiyama M, Kodama K, Yokouchi H, et al. Prognostic value of bronchiolo-alveolar carcinoma component of small lung adenocarcinoma. Ann Thorac Surg 1999;68:2069–2073.

    Article  PubMed  CAS  Google Scholar 

  37. Nakata M, Sawada S, Yamashita M, et al. Objective radiologic analysis of ground-glass opacity aimed at curative limited resection for small peripheral non-small cell lung cancer. J Thorac Cardiovasc Surg 2005;129:1226–1231.

    Article  PubMed  Google Scholar 

  38. Nakata M, Sawada S, Yamashita M, et al. Surgical treatments for multiple primary adenocarcinoma of the lung. Ann Thorac Surg 2004;78:1194–1199.

    Article  PubMed  Google Scholar 

  39. Okada M, Tsubota N, Yoshimura M, et al. Operative approach for multiple primary lung carcinomas. J Thorac Cardiovasc Surg 1998;115:836–840.

    Article  PubMed  CAS  Google Scholar 

  40. Battafarano RJ, Meyers BF, Guthrie TJ, et al. Surgical resection of multifocal non-small cell lung cancer is associated with prolonged survival. Ann Thorac Surg 2002;74:988–994.

    Article  PubMed  Google Scholar 

  41. Donker R, Stewart DJ, Dharouge S, et al. Clinical characteristics and the impact of surgery and chemotherapy on survival of patients with advanced and metastatic bronchioloalveolar carcinoma: a retrospective study. Clin Lung Cancer 2000;1:211–215.

    Article  PubMed  CAS  Google Scholar 

  42. Roberts PF, Straznicka M, Lara PN, et al. Resection of multifocal non-small cell lung cancer when the bronchioloalveolar subtype is involved. J Thorac Cardiovasc Surg 2003;126:1597–1602.

    Article  PubMed  Google Scholar 

  43. Zorn GL, McGiffin DC, Young RK, et al. Pulmonary transplantation for advanced bronchioloalveolar carcinoma. J Thorac Cardiovasc Surg 2003;125:45–48.

    Article  PubMed  Google Scholar 

  44. Paloyan EB, Swinnen LJ, Montoya A, et al. Lung transplantation for advanced bronchioloalveolar carcinoma confined to the lungs. Transplantation 2000;69:2446–2448.

    Article  PubMed  CAS  Google Scholar 

  45. Barlesi F, Doddoli C, Thomas P, et al. Bilateral bronchioloalveolar lung carcinoma: is there a place for palliative pneumonectomy? Eur J Cardiothorac Surg 2001;20:1113–1116.

    Article  PubMed  CAS  Google Scholar 

  46. DeGrendele H, Belani CP, Perry MC. Epidermal growth factor inhibitors, gefitinib and erlotinib (Tarceva, OS1-774), in the treatment of bronchioloalveolar carcinoma. Clin Lung Cancer 2003;83–85.

    Google Scholar 

  47. Miller VA, Kris MG, Shah N, et al. Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small cell lung cancer. J Clin Oncol 2004;22:1103–1109.

    Article  PubMed  CAS  Google Scholar 

  48. Gandara DR, West H, Chansky K, et al. Bronchioloalveolar carcinoma: a model for investigating the biology of epidermal growth factor receptor inhibition. Clin Cancer Res 2004;10:4205–4209.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag London Limited

About this chapter

Cite this chapter

Deb, S.J., Deschamps, C. (2007). Surgery for Bronchoalveolar Lung Cancer. In: Ferguson, M.K. (eds) Difficult Decisions in Thoracic Surgery. Springer, London. https://doi.org/10.1007/978-1-84628-474-8_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-474-8_20

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-384-0

  • Online ISBN: 978-1-84628-474-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics